Eugene Huh
Overview
Explore the profile of Eugene Huh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
36
Citations
254
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kim J, Huh E, Eo H, Kim J, Kwon Y, Ju I, et al.
Metab Brain Dis
. 2024 Dec;
40(1):69.
PMID: 39699803
Parkinson's disease (PD) is a neurodegenerative disease characterized by the loss of dopaminergic neurons. In particular, neuroinflammation associated with phosphorylation of c-Jun N-terminal kinase (JNK) is likely to cause the...
2.
Kim J, Kim J, Ju I, Huh E, Choi Y, Lee S, et al.
Biomol Ther (Seoul)
. 2024 Aug;
32(5):523-530.
PMID: 39092515
Parkinson's disease (PD) is a neurodegenerative disease caused by the death of dopaminergic neurons in the nigrostriatal pathway, leading to motor and non-motor dysfunctions, such as depression, olfactory dysfunction, and...
3.
Huh E, Choi J, Choi Y, Ju I, Kim B, Shin Y, et al.
EBioMedicine
. 2023 Nov;
98:104887.
PMID: 37995468
Background: Recent studies suggesting the importance of the gut-microbiome in intestinal aggregated alpha synuclein (α-syn) have led to the exploration of the possible role of the gut-brain axis in central...
4.
Huh E, Choi J, Lee M, Kim J, Choi Y, Ju I, et al.
Front Mol Neurosci
. 2023 Aug;
16:1201073.
PMID: 37635904
Introduction: Parkinson's disease (PD) is a representative neurodegenerative disease, and its diagnosis relies on the evaluation of clinical manifestations or brain neuroimaging in the absence of a crucial noninvasive biomarker....
5.
Eo H, Kim S, Ju I, Huh E, Kim S, Choi J, et al.
Front Nutr
. 2023 Jul;
10:1143613.
PMID: 37415911
Type 2 diabetes mellitus (T2DM) is one of the biggest public health issues worldwide and closely related to development of other chronic diseases such as cardiovascular diseases, cancer and neurodegenerative...
6.
Huh E, Choi J, Choi Y, Ju I, Noh D, Shin D, et al.
Biomol Ther (Seoul)
. 2023 Jun;
31(4):417-424.
PMID: 37337830
Parkinson's disease (PD) which has various pathological mechanisms, recently, it is attracting attention to the mechanism via microbiome-gut-brain axis. 6-Shogaol, a representative compound of ginger, have been known for improving...
7.
Choi Y, Huh E, Lee S, Kim J, Park M, Seo S, et al.
Biomol Ther (Seoul)
. 2023 Mar;
31(4):402-410.
PMID: 36918741
Long-term administration of levodopa (L-DOPA) to patients with Parkinson's disease (PD) commonly results in involuntary dyskinetic movements, as is known for L-DOPA-induced dyskinesia (LID). 5-Hydroxytryptophan (5-HTP) has recently been shown...
8.
Ju I, Lee S, Choi J, Kim N, Huh E, Lee J, et al.
Phytother Res
. 2023 Feb;
37(7):2854-2863.
PMID: 36814130
Alzheimer's disease (AD) is the most common neurodegenerative disease characterized by amyloid-β (Aβ) deposition, accompanied by neuroinflammation and memory dysfunction. Houttuyniae Herba (aerial parts of Houttuynia cordata, also known as...
9.
Kim J, Ju I, Kim N, Huh E, Son S, Hong J, et al.
Antioxidants (Basel)
. 2023 Jan;
12(1).
PMID: 36670968
Neuroinflammation causes various neurological disorders, including depression and neurodegenerative diseases. Therefore, regulation of neuroinflammation is a promising therapeutic strategy for inflammation-related neurological disorders. This study aimed to investigate whether yomogin,...
10.
Ju I, Son S, Lee S, Im H, Huh E, Eo H, et al.
Biomed Pharmacother
. 2022 Dec;
158:114105.
PMID: 36508997
Alzheimer's disease (AD) is the most common dementia characterized by the excessive accumulation of amyloid-beta (Aβ) and tau aggregates, as well as neuronal damage and neuroinflammation. Metabolic disruption in AD...